Applied Biosciences Corp
OTC:APPB
Balance Sheet
Balance Sheet Decomposition
Applied Biosciences Corp
Applied Biosciences Corp
Balance Sheet
Applied Biosciences Corp
| Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
1
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
2
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
2
|
|
| Total Assets |
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
1
-58%
|
4
+418%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Liabilities |
0
N/A
|
0
+650%
|
0
-39%
|
0
+306%
|
0
-19%
|
2
+5 538%
|
|
| Equity | |||||||
| Common Stock |
0
|
3
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
0
|
1
|
3
|
6
|
|
| Additional Paid In Capital |
0
|
3
|
0
|
2
|
3
|
7
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Equity |
0
N/A
|
0
N/A
|
0
+39%
|
2
N/A
|
1
-59%
|
2
+215%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
1
-58%
|
4
+418%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
1
|
0
|
10
|
15
|
10
|
13
|
|